Danaher Corp., US2358511028

Danaher Stock - weekly sector check and peer comparison

19.06.2026 - 15:26:17 | ad-hoc-news.de

Danaher stock closes the week with a muted price pattern while investors weigh the group’s life-sciences exposure against peers in diagnostics and industrial technology. A look at recent performance, sector backdrop and upcoming catalysts.

Danaher Corp., US2358511028
Danaher Corp., US2358511028

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:24 UTC. Details in the imprint.

Danaher (US2358511028) remains a core name in the US life-sciences and diagnostics sector, with the stock trading in a narrow range this week on the New York Stock Exchange. Investors continue to benchmark the group against large-cap peers in tools, diagnostics and industrial technology.

Go deeper

All news and key data on Danaher stock

Current articles, price data and regulatory filings on Danaher stock can be found bundled on the ad hoc news topic page and in the company’s own investor-relations section.

How Danaher closed the week

Danaher shares last closed at $177.74 on 06/18/2026, essentially unchanged on the day according to price data compiled by MarketBeat. That level leaves the stock broadly mid-range compared with its trading band over recent months.

Extended trading on the same date showed Danaher shares at $177.53, a marginal 0.1% move below the regular session close. The muted action underlines a lack of fresh company-specific catalysts in the past few days.

Positioning versus life-science peers

Within the broader life-sciences tools and diagnostics group, Danaher is often discussed alongside large US peers such as Thermo Fisher Scientific and Abbott Laboratories in analyst sector work. The shared exposure includes bioprocessing, laboratory instruments and clinical diagnostics.

On balance, the sector backdrop in 2026 remains mixed, with soft biopharma capital spending offset by stable demand in clinical diagnostics and water-quality solutions. Against this backdrop, investors are comparing balance-sheet flexibility and margin resilience across the peer group.

Where Danaher generates its revenue

Danaher derives revenue from a portfolio of life sciences, diagnostics and biotechnology businesses, including platforms such as Cytiva bioprocessing equipment, Beckman Coulter clinical analyzers and Leica branded microscopes used in research and healthcare laboratories.

Where the stock trades today

The shares of Danaher (US2358511028) trade on the New York Stock Exchange at $177.74 as of 06/18/2026, 15:59 Eastern Time.

Key facts on Danaher stock

  • Company: Danaher Corp.
  • ISIN: US2358511028
  • WKN: 866197
  • Ticker: DHR
  • Venue: NYSE
  • Price (as of 06/18/2026, 15:59 Eastern Time): 177.74 USD
  • Market cap: 131,000,000,000 USD (as of 06/18/2026)
  • Sector / Industry: Health Care / Life Sciences Tools & Services
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Danaher stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US2358511028 | DANAHER CORP. | boerse | 69582923 | bgmi